Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Heinzer

Showing results (91-100 of 145) with videos related to

Pageof 15
Sort By:
Prostate Cancer and Prostatic Diseases|June 11, 2024
Nerve-sparing radical prostatectomy using the neurovascular structure-adjacent frozen-section examination (NeuroSAFE): results after 20 years of experienceFrancesca Ambrosini, Felix Preisser, Derya Tilki, et al.
Plos One|June 2, 2015
Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate CancersChristoph Burdelski, Erzen Bujupi, Maria Christina Tsourlakis, et al.
BJU International|September 24, 2013
Prospective randomized double-blind multicentre phase II study comparing gemcitabine and cisplatin plus sorafenib chemotherapy with gemcitabine and cisplatin plus placebo in locally advanced and/or metastasized urothelial cancer: SUSE (AUO-AB 31/05)Susanne Krege, Heidrun Rexer, Frank vom Dorp, et al.
Oncotarget|March 13, 2015
Overexpression of thymidylate synthase (TYMS) is associated with aggressive tumor features and early PSA recurrence in prostate cancerChristoph Burdelski, Christian Strauss, Maria Christina Tsourlakis, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 27, 2013
High nuclear karyopherin α 2 expression is a strong and independent predictor of biochemical recurrence in prostate cancer patients treated by radical prostatectomyKatharina Grupp, Mareike Habermann, Hüseyin Sirma, et al.
BJU International|April 13, 2007
Health-insurance status is a determinant of the stage at presentation and of cancer control in European men treated with radical prostatectomy for clinically localized prostate cancerAndrea Gallina, Pierre I Karakiewicz, Felix K-H Chun, et al.
The Prostate|July 12, 2013
SPINK1 expression is tightly linked to 6q15- and 5q21-deleted ERG-fusion negative prostate cancers but unrelated to PSA recurrenceKatharina Grupp, Franz Diebel, Hüseyin Sirma, et al.
Oncology Letters|October 19, 2018
High concordance of TMPRSS-ERG fusion between primary prostate cancer and its lymph node metastasesFranziska Brandi, Katharina Grupp, Claudia Hube-Magg, et al.
The Prostate|January 15, 2016
Cytoplasmic accumulation of ELAVL1 is an independent predictor of biochemical recurrence associated with genomic instability in prostate cancerNathaniel Melling, Berivan Taskin, Claudia Hube-Magg, et al.
European Urology|October 3, 2006
Development and external validation of an extended 10-core biopsy nomogramFelix K-H Chun, Alberto Briganti, Markus Graefen, et al.
Pageof 15

Showing results (91-100 of 145) with videos related to

Sort By:
Pageof 15
Prostate Cancer and Prostatic Diseases|June 11, 2024
Nerve-sparing radical prostatectomy using the neurovascular structure-adjacent frozen-section examination (NeuroSAFE): results after 20 years of experienceFrancesca Ambrosini, Felix Preisser, Derya Tilki, et al.
Plos One|June 2, 2015
Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate CancersChristoph Burdelski, Erzen Bujupi, Maria Christina Tsourlakis, et al.
BJU International|September 24, 2013
Prospective randomized double-blind multicentre phase II study comparing gemcitabine and cisplatin plus sorafenib chemotherapy with gemcitabine and cisplatin plus placebo in locally advanced and/or metastasized urothelial cancer: SUSE (AUO-AB 31/05)Susanne Krege, Heidrun Rexer, Frank vom Dorp, et al.
Oncotarget|March 13, 2015
Overexpression of thymidylate synthase (TYMS) is associated with aggressive tumor features and early PSA recurrence in prostate cancerChristoph Burdelski, Christian Strauss, Maria Christina Tsourlakis, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 27, 2013
High nuclear karyopherin α 2 expression is a strong and independent predictor of biochemical recurrence in prostate cancer patients treated by radical prostatectomyKatharina Grupp, Mareike Habermann, Hüseyin Sirma, et al.
BJU International|April 13, 2007
Health-insurance status is a determinant of the stage at presentation and of cancer control in European men treated with radical prostatectomy for clinically localized prostate cancerAndrea Gallina, Pierre I Karakiewicz, Felix K-H Chun, et al.
The Prostate|July 12, 2013
SPINK1 expression is tightly linked to 6q15- and 5q21-deleted ERG-fusion negative prostate cancers but unrelated to PSA recurrenceKatharina Grupp, Franz Diebel, Hüseyin Sirma, et al.
Oncology Letters|October 19, 2018
High concordance of TMPRSS-ERG fusion between primary prostate cancer and its lymph node metastasesFranziska Brandi, Katharina Grupp, Claudia Hube-Magg, et al.
The Prostate|January 15, 2016
Cytoplasmic accumulation of ELAVL1 is an independent predictor of biochemical recurrence associated with genomic instability in prostate cancerNathaniel Melling, Berivan Taskin, Claudia Hube-Magg, et al.
European Urology|October 3, 2006
Development and external validation of an extended 10-core biopsy nomogramFelix K-H Chun, Alberto Briganti, Markus Graefen, et al.
Pageof 15